Kyle completed his PhD in Bioengineering at McMaster University under the supervision of Dr. Zeinab Hosseinidoust (Department of Chemical Engineering). He joins the Verdu Lab as a Research Consultant, advancing the group’s efforts to develop microbial-targeted therapeutics using bacterial viruses (bacteriophages). In addition to his research role, Kyle serves as the Business Development Officer at the Heersink School of Biomedical Innovation at McMaster University, where he supports the growth of emerging healthcare startups and helps prepare them for engagement with external stakeholders and partners.